UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Effects of IV Administration of Ketamine on the Analgesia Nociception Index (ANI) Measured With the PhysioDoloris

Completed

Conditions: Monitoring, Intraoperative

First Posted Date: 2012-10-30

Last Posted Date: 2019-08-05

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT01717521

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)

Not Applicable

Completed

Conditions: Alzheimer's Disease
Dementia
Memory Impairment
Cognitive Impairment

Interventions: Behavioral: RDAD

First Posted Date: 2012-10-16

Last Posted Date: 2017-09-15

Lead Sponsor: University of Washington

Target Recruit Count: 510

Registration Number: NCT01708304

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma

Phase 2

Active, not recruiting

Conditions: Recurrent Hodgkin Lymphoma
Recurrent Non-Hodgkin Lymphoma
Refractory Hodgkin Lymphoma
Refractory Non-Hodgkin Lymphoma

Interventions: Drug: Brentuximab Vedotin
Other: Laboratory Biomarker Analysis
Biological: Nivolumab

First Posted Date: 2012-10-11

Last Posted Date: 2025-03-10

Lead Sponsor: University of Washington

Target Recruit Count: 28

Registration Number: NCT01703949

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Cabozantinib in Men With Castration-Resistant Prostate Cancer

Phase 2

Terminated

Conditions: Castration-resistant Prostate Cancer
Stage III Prostate Cancer
Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions: Drug: Cabozantinib

First Posted Date: 2012-10-10

Last Posted Date: 2018-12-04

Lead Sponsor: University of Washington

Target Recruit Count: 9

Registration Number: NCT01703065

Locations: 🇺🇸
Seattle Cancer Care Alliance/University of Washington, Seattle, Washington, United States

Cognitive Behavioral Therapy for COPD

Not Applicable

Completed

Conditions: COPD
Depression

Interventions: Behavioral: CLIMB (COPD Lifestyle, Mood, and Behavior)

First Posted Date: 2012-09-27

Last Posted Date: 2021-10-05

Lead Sponsor: University of Washington

Target Recruit Count: 18

Registration Number: NCT01694628

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin

Phase 1

Completed

Conditions: Insulin Resistance
Type 2 Diabetes Mellitus
Obesity
Androgen Deficiency
Metabolic Disease

Interventions: Drug: Acyline
Drug: Testosterone 1.62% gel
Drug: Placebo gel (for Testosterone 1.62% gel)
Drug: Placebo pill (for Letrozole)
Drug: Letrozole

First Posted Date: 2012-09-18

Last Posted Date: 2018-05-08

Lead Sponsor: University of Washington

Target Recruit Count: 53

Registration Number: NCT01686828

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease

Not Applicable

Completed

Conditions: Diabetes

Interventions: Drug: Omega-3 fatty acids (fish oil)
Dietary Supplement: Vitamin D
Dietary Supplement: Fish oil placebo
Dietary Supplement: Vitamin D placebo

First Posted Date: 2012-09-13

Last Posted Date: 2022-06-21

Lead Sponsor: University of Washington

Target Recruit Count: 1312

Registration Number: NCT01684722

Locations: 🇺🇸
Brigham Women's Hospital, Boston, Massachusetts, United States

Washington State Community Expedited Partner Treatment (EPT) Trial

Phase 4

Completed

Conditions: Gonorrhea
Neisseria Gonorrhoeae
Chlamydia Trachomatis

Interventions: Other: Patient delivered partner therapy
Behavioral: Targeted public health partner services

First Posted Date: 2012-08-15

Last Posted Date: 2012-08-17

Lead Sponsor: University of Washington

Target Recruit Count: 33222

Registration Number: NCT01665690

Locations: 🇺🇸
Washington State Department of Health, Olympia, Washington, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Sequence of Symptom Change During AUD or PTSD Treatment for Comorbid PTSD/AUD

Not Applicable

Conditions: Alcohol Abuse
Alcohol Dependence
PTSD

Interventions: Behavioral: Relapse Prevention (RP)
Behavioral: Cognitive Processing Therapy (CPT)

First Posted Date: 2012-08-13

Last Posted Date: 2018-07-18

Lead Sponsor: University of Washington

Target Recruit Count: 235

Registration Number: NCT01663337

Locations: 🇺🇸
Harborview Center for Sexual Assault and Traumatic Stress, Seattle, Washington, United States
🇺🇸
VA Puget Sound Health Care (Seattle Campus), Seattle, Washington, United States

Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms

Not Applicable

Completed

Conditions: Cancer Survivor
Breast Carcinoma
Malignant Female Reproductive System Neoplasm
Cognitive Side Effects of Cancer Therapy

Interventions: Other: Cognitive Intervention
Other: Educational Intervention
Procedure: Functional Magnetic Resonance Imaging
Other: Memory Intervention
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2012-07-16

Last Posted Date: 2019-11-08

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT01641068

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy